Barbara Burtness, MD | Authors

December 08, 2015

Burtness says on average, medical professionals should take about 4 minutes or longer to properly explain the clinical trial to their patients, as well as leave ample time for questions at the end of the conversation.

November 26, 2014

Barbara Burtness, MD, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.

September 27, 2014

Barbara Burtness, MD, discusses immune checkpoint inhibitors for head and neck cancers.